Structure elucidation of phase i metabolites of the microtubule perturbagens: Ceratamines A and B

Journal of Natural Products

Volumn 77, Issue 7, 2014, Pages 1572-1578

  Smith, Sara E ^a   Dello Buono, Matthew C ^a   Carper, Daniel J ^b   Coleman, Robert S ^b   Day, Billy W ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID DERIVATIVE; ANTIMITOTIC AGENT; CERATAMINES A; CERATAMINES B; DRUG METABOLITE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DEMETHYLATION; DRUG STRUCTURE; IN VITRO STUDY; LIQUID CHROMATOGRAPHY; LIVER MICROSOME; MICROSOME; MICROTUBULE; NONHUMAN; OXYGENATION; PROTON NUCLEAR MAGNETIC RESONANCE; QUALITATIVE ANALYSIS; RAT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TANDEM MASS SPECTROMETRY; ULTRAVIOLET RADIATION;

ALKALOIDS; ALZHEIMER DISEASE; ANIMALS; ANTINEOPLASTIC AGENTS; AZEPINES; BRAIN; HYDROCARBONS, BROMINATED; IMIDAZOLES; INHIBITORY CONCENTRATION 50; MARINE BIOLOGY; MICROSOMES, LIVER; MICROTUBULES; MOLECULAR STRUCTURE; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PORIFERA; RATS;

EID: 84905020963     PISSN: 01633864     EISSN: 15206025     Source Type: Journal    
DOI: 10.1021/np4010882     Document Type: Article

References (18)

1. Molinski, T.; Dalisay, D.; Lievens, S.; Saludes, J. Nat. Rev. 2009, 8, 69-85
2. Cragg, G. Med. Res. Rev. 1998, 18, 315-331
3. Georg, G.; Chen, T.; Ojima, I.; Vyas, D. ACS Symp. Ser. 1994, 583, 1-3
4. Rowinsky, E. Annu. Rev. Med. 1997, 48, 353-374
5. Cooper, G. The Cell: A Molecular Approach, 2 nd ed., Sinauer Associates: Sunderland, MA, 2000.
6. Jordan, M.; Wilson, L. Nat. Rev. Cancer 2004, 4, 253-265
7. Wittman, T.; Hyman, A.; Desai, A. Nat. Cell Biol. 2001, 3, 28-34
8. Kirschner, M.; Mitchison, T. Cell 1986, 45, 329-342
9. Stanton, R.; Gernert, K.; Nettles, J.; Aneja, R. Med. Res. Rev. 2011, 31, 443-481
10. Roberge, M.; Cinel, B.; Andersen, H.; Lim, L.; Jiang, X.; Xu, L.; Bigg, C.; Kelly, M.; Andersen, R. Cancer Res. 2000, 60, 5052-5058
11. Galletti, M.; Maghani, M.; Renzulli, M.; Botta, M. ChemMedChem. 2007, 2, 920-942
12. Martello, L.; McDaid, H.; Regl, D.; Yang, C.; Meng, D.; Pettus, T.; Kaufman, M.; Arimoto, H.; Danishefsky, S.; Smith, A., III; Horwitz, S. Clin. Cancer Res. 2000, 6, 1978-1987
13. Karjala, G.; Can, Q.; Manzo, E.; Andersen, R.; Roberge, M. Cancer Res. 2005, 65, 3040-3043
14. ter Haar, E.; Kowalski, R.; Hamel, E.; Lin, C.; Longley, R.; Gunasekera, S.; Rosenkranz, H.; Day, B. Biochemistry 1996, 35, 243-250
15. Coleman, R.; Campbell, E.; Carper, D. Org. Lett. 2009, 11, 2133-2136
16. Ballatore, C.; Brunden, K.; Huryn, D.; Trojanowski, J.; Lee, V.; Smith, A. J. Med. Chem. 2012, 55, 8979-8996
17. Coleman, M. Human Drug Metabolism: An Introduction; Wiley-Blackwell: Hoboken, NJ, 2010.
18. Pasto, D.; Johnson, C. Organic Structure Determination; Prentice-Hall, Inc.: Englewood Cliffs, NJ, 1969; pp 83-108.